Takeda Pharmaceutical (TAK) Non-Current Assets: 2018-2025

Historic Non-Current Assets for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $77.0 billion.

  • Takeda Pharmaceutical's Non-Current Assets fell 9.23% to $76.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $76.9 billion, marking a year-over-year decrease of 9.23%. This contributed to the annual value of $77.0 billion for FY2025, which is 11.53% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Non-Current Assets of $77.0 billion as of FY2025, which was down 11.53% from $87.0 billion recorded in FY2024.
  • In the past 5 years, Takeda Pharmaceutical's Non-Current Assets ranged from a high of $96.2 billion in FY2021 and a low of $77.0 billion during FY2025.
  • For the 3-year period, Takeda Pharmaceutical's Non-Current Assets averaged around $83.2 billion, with its median value being $85.6 billion (2023).
  • In the last 5 years, Takeda Pharmaceutical's Non-Current Assets rose by 1.70% in 2024 and then dropped by 11.53% in 2025.
  • Takeda Pharmaceutical's Non-Current Assets (MRY) stood at $96.2 billion in 2021, then dropped by 2.01% to $94.3 billion in 2022, then decreased by 9.24% to $85.6 billion in 2023, then rose by 1.70% to $87.0 billion in 2024, then fell by 11.53% to $77.0 billion in 2025.
  • Its Non-Current Assets stands at $77.0 billion for FY2025, versus $87.0 billion for FY2024 and $85.6 billion for FY2023.